meriggioli matthew (35 risultati)

Condizione: New.

Condizione: New.

Condizione: New.

Condizione: New.

Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condizione: As New. Unread book in perfect condition.

Condizione: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.

Condizione: As New. Unread book in perfect condition.

Condizione: New. pp. xi + 300 1st Edition.

Paperback. Condizione: new. Paperback. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Continued efforts in the last decades have begun to produce significant progress in our understanding of this rare condition, yet considerable challenges remain for improving diagnosis and developing effective treatments for MG. The present volume comprises papers stemming from the 12th International Conference on Myasthenia Gravis and Related Disorders, held May 2123, 2012 at the New York Academy of Sciences in New York City. The papers collected in this second of two Annals volumes highlight some of the key developments in neuroscience and immunology in MG and related syndromes presented at the conference, including treatment update and what lies ahead, congenital myasthenic syndromes, Lambert-Eaton myasthenic syndrome, the thymus, thymectomy, and the myasthenia gravis thymectomy trial, and hot topics selected from submitted abstracts. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order . Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please aspx for more information on becoming a member. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Condizione: Very Good. Condizione sovraccoperta: None. 300 pages. Previous owner's inscription on title page. Light soil to rear cover, else a clean, tight copy. Record # 464592.

Paperback. Condizione: new. Paperback. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Continued efforts in the last decades have begun to produce significant progress in our understanding of this rare condition, yet considerable challenges remain for improving diagnosis and developing effective treatments for MG. The present volume comprises papers stemming from the 12th International Conference on Myasthenia Gravis and Related Disorders, held May 2123, 2012 at the New York Academy of Sciences in New York City. The papers collected in this first of two Annals volumes highlight some of the key developments in neuroscience and immunology in MG and related syndromes presented at the conference, including structure and function of the neuromuscular junction, advances in immunology and their relationship to myasthenia gravis, clinical and laboratory developments, outcome measurements and clinical trial development, and animal models of neuromuscular junction disease. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order . Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please aspx for more information on becoming a member. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

Condizione: New. pp. xi + 300.

Condizione: As New. Unread book in perfect condition.

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Condizione: New. Brand new! Please provide a physical shipping address.

Paperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.

Paperback. Condizione: New.

Condizione: New. Brand new! Please provide a physical shipping address.

Condizione: New. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Editor(s): Wolfe, Gil I.; Ciafalonia, Emma; Ruff, Robert; Meriggioli, Matthew N. Series: Annals of the New York Academy of Sciences. Num Pages: 252 pages. BIC Classification: MJE. Category: (P) Professional & Vocational. Dimension: 253 x 179 x 6. Weight in Grams: 320. . 2013. 1st Edition. Paperback. . . . .

Condizione: New. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Editor(s): Wolfe, Gil I.; Ciafalonia, Emma; Ruff, Robert; Meriggioli, Matthew N. Series: Annals of the New York Academy of Sciences. Num Pages: 252 pages, Illustrations. BIC Classification: MJE. Category: (P) Professional & Vocational. Dimension: 255 x 181 x 10. Weight in Grams: 346. . 2013. 1st Edition. Paperback. . . . .

Condizione: New.

Paperback. Condizione: Brand New. 1st edition. 252 pages. 10.00x0.28x7.00 inches. In Stock.

Condizione: New. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Editor(s): Wolfe, Gil I.; Ciafalonia, Emma; Ruff, Robert; Meriggioli, Matthew N. Series: Annals of the New York Academy of Sciences. Num Pages: 252 pages. BIC Classification: MJE. Category: (P) Professional & Vocational. Dimension: 253 x 179 x 6. Weight in Grams: 320. . 2013. 1st Edition. Paperback. . . . . Books ship from the US and Ireland.

Condizione: New. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Editor(s): Wolfe, Gil I.; Ciafalonia, Emma; Ruff, Robert; Meriggioli, Matthew N. Series: Annals of the New York Academy of Sciences. Num Pages: 252 pages, Illustrations. BIC Classification: MJE. Category: (P) Professional & Vocational. Dimension: 255 x 181 x 10. Weight in Grams: 346. . 2013. 1st Edition. Paperback. . . . . Books ship from the US and Ireland.

Paperback. Condizione: new. Paperback. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Continued efforts in the last decades have begun to produce significant progress in our understanding of this rare condition, yet considerable challenges remain for improving diagnosis and developing effective treatments for MG. The present volume comprises papers stemming from the 12th International Conference on Myasthenia Gravis and Related Disorders, held May 2123, 2012 at the New York Academy of Sciences in New York City. The papers collected in this second of two Annals volumes highlight some of the key developments in neuroscience and immunology in MG and related syndromes presented at the conference, including treatment update and what lies ahead, congenital myasthenic syndromes, Lambert-Eaton myasthenic syndrome, the thymus, thymectomy, and the myasthenia gravis thymectomy trial, and hot topics selected from submitted abstracts. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order . Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please aspx for more information on becoming a member. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Paperback. Condizione: new. Paperback. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Continued efforts in the last decades have begun to produce significant progress in our understanding of this rare condition, yet considerable challenges remain for improving diagnosis and developing effective treatments for MG. The present volume comprises papers stemming from the 12th International Conference on Myasthenia Gravis and Related Disorders, held May 2123, 2012 at the New York Academy of Sciences in New York City. The papers collected in this first of two Annals volumes highlight some of the key developments in neuroscience and immunology in MG and related syndromes presented at the conference, including structure and function of the neuromuscular junction, advances in immunology and their relationship to myasthenia gravis, clinical and laboratory developments, outcome measurements and clinical trial development, and animal models of neuromuscular junction disease. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order . Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please aspx for more information on becoming a member. Myasthenia gravis (MG), an acquired immune syndrome affecting proteins at the neuromuscular junction, causes significant muscular functional impairment and can compromise patients quality of life, including fatigue, disability, and increased mortality rates. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.